"Journal watch." Pain Management, 4(4), pp. 259–260
Financial & competing interests disclosure
N Finnerup receives research funding from the EUROPAIN Investigational Medicines Initiative, which is a public-private partnership between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and EU. N Finnerup has also received honoraria from Pfizer and Grünenthal. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Additional information
Funding
N Finnerup receives research funding from the EUROPAIN Investigational Medicines Initiative, which is a public-private partnership between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and EU. N Finnerup has also received honoraria from Pfizer and Grünenthal. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.